,,ii  #aac? ,,congress  #b;d ,session   
,s4 #bacd  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,m>* #ac1 #bjad ,mr4   
,man*9 introduc$ ! foll[+ bill2 :i* 0   
read twice & ref]r$ to ! ,committee on  
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to )draw approval = ! drug  
,zohydro ,,er & prohibit ! ,food & ,drug
 ,adm9i/ration f approv+ su* drug unless
 x is re=mulat$ to prev5t abuse4  #a4   
,%ort title  ,?is ,act may be cit$ z !  
,act to ,ban ,zohydro4  #b4  ,f9d+s     
,congress f9ds z foll[s3  7#a7 ,! drug  
,zohydro ,,er is a high-dose            
hydrocone-only opioid n>cotic pa9kill]  
li/$ 9 s*$ule ,,ii ( section #bjb7;c7 ( 
! ,controll$ ,sub/ances ,act 7#ba       
,u4,s4,c4 #hab7;c774  7#b7 ,! ,food &   
,drug ,adm9i/ration ,ane/hetic &        
,analgesic ,drug ,products ,advisory    
,committee report cit$ available dosages
 ( ,zohydro ,,er t1 accord+ to heal? c>e
 & sub/ance abuse pr(essionals1 h up to 
#aj times m hydrocodone ?an any         
hydrocodone pa9kill] curr5tly on !      

m>ket4  7#c7 ,zohydro ,,er is           
manufactur$ )\t an abuse det]r5t        
=mulation4  7#d7 ,zohydro's "t-releas$  
effect1 an important elem5t ( its       
ph>maceutical use1 is easily negat$ by  
abus]s to a*ieve a h]o9-l effect4  7#e7 
,! ,ane/hetic & ,analgesic ,drug        
,products ,advisory ,committee conclud$ 
t1 if approv$ & m>ket$1 ,zohydro ,,er w 
be abus$1 possibly at a rate great] ?an 
t ( curr5tly available hydrocodone      
comb9ation products4  7#f7 ,! ,ane/hetic
 & ,analgesic ,drug ,products ,advisory 
,committee vot$ #aa to #b aga9/ approval
 ( ,zohydro ,,er1 cit+ ! high           
possibility = addiction4  7#g7 ,! ,food 
& ,drug ,adm9i/ration approv$ ,zohydro  
,,er )\t an abuse det]r5t =mulation     
despite ! fact t ! ,ane/hetic &         
,analgesic ,drug ,products ,advisory    
,committee vot$ #aa to #b aga9/ do+ s4  
7#h7 ,! ,food & ,drug ,adm9i/ration has 
ackn[l$g$ t ! widespread abuse ( opioid 
drugs across ! c\ntry has rea*$ epidemic
 proportions 9 "s p>ts ( ! c\ntry4  7#i7

 ,accord+ to ! ,c5t]s = ,disease        
,control & ,prev5tion1 dea?s connect$ to
 prescription opioids h m ?an quadrupl$ 
9 ! ,unit$ ,/ates1 f #d1jcj dea?s       
involv+ ! pa9kill]s 9 #aiii to #af1fea  
dea?s 9 #bjaj4  7#aj7 ,! ,c5t]s =       
,disease ,control & ,prev5tion has      
id5tifi$ r$uc+ dea?s attributable to    
prescription pa9kill] abuse & ov]dose z 
a top heal? priority = #bjad4  7#aa7    
,attorneys ,g5]al f #bh ,/ates h ask$ ! 
,food & ,drug ,adm9i/ration to reconsid]
 its approval ( ,zohydro ,,er4  7#ab7   
,heal? c>e pr(essionals1 addiction      
treatm5t provid]s1 & community-bas$ drug
 & alcohol prev5tion programs are gr\ps 
oppos$ to ! approval ( ,zohydro ,,er4   
7#ac7 ,! burd5s ( ,zohydro ,,er to !    
public heal? outweigh its pot5tial      
!rapeutic b5efits4 ,giv5 t alt]native   
pa9 m$ic9es & me?ods are widely         
available1 approval ( ,zohydro ,,er %\ld
 be )drawn until su* "t t !re is        
available a ,food & ,drug               
,adm9i/ration-approv$ abuse det]r5t     

=mulation4  #c4  ,)drawal ( approval (  
drug ,zohydro ,,er  7a7  ,)drawal (     
approval  ,effective beg9n+ on ! day t  
is #de days aft] ! date ( enactm5t ( ?is
 ,act1 approval ( ! application )       
respect to pure hydrocodone bit>trate   
ext5d$-release capsules 7m>ket$ z ! drug
 ,zohydro ,,er7 "u section #eje7;c7 ( ! 
,f$]al ,food1 ,drug1 & ,cosmetic ,act   
7#ba ,u4,s4,c4 #cee7;c77 is deem$ to h  
be5 )drawn "u section #eje7;e7 ( su*    
,act 7#ba ,u4,s4,c4 #cee7;e774  7b7  ,no
 approval ( any =mulation t is n abuse  
det]r5t  ,! ,commission] ( ,food &      
,drugs %all n approve any application "u
 section #eje ( ! ,f$]al ,food1 ,drug1 &
 ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 =  
pure hydrocodone bit>trate              
ext5d$-release capsules unless su* drug 
is =mulat$ to prev5t abuse4